QualityStocksNewsBreaks Archives - Page 12 of 1407

TuesdayJul 29, 2025 9:35 am

QualityStocksNewsBreaks – Onar Holding Corporation (OTCQB: ONAR) Expands Strategic Partnership with IQSTEL (NASDAQ: IQST) to Launch AI-Driven Multi-Agentic Operating Infrastructure

Onar (OTCQB: ONAR), a marketing technology company and global agency network, announced an expanded partnership with IQSTEL, Inc. (NASDAQ: IQST) and its AI subsidiary Reality Border to develop a next-generation AI-driven, multi-agentic operating infrastructure. Building on ONAR’s 2024 rebranding of IQSTEL, the initiative will integrate dedicated AI agents for every ONAR employee and client account, streamlining operations, enhancing performance optimization, and enabling real-time strategic insights. CEO Claude Zdanow said the system amplifies human potential by automating repetitive processes while preserving data security. The three-phase rollout will introduce operational streamlining, strategic enablement, and creative augmentation, positioning ONAR at the forefront of…

TuesdayJul 29, 2025 9:10 am

QualityStocksNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Drivers Deliver Strong Results at Laguna Seca

SEGG Media (NASDAQ: SEGG, LTRYW), a technology company at the intersection of sports, entertainment and gaming, showcased its Sports.com and Lottery.com brands during the Java House Grand Prix of Monterey at WeatherTech Raceway Laguna Seca. Callum Ilott surged from P24 to finish P6, marking PREMA Racing’s best-ever NTT INDYCAR Series result. Louis Foster qualified P7, maintaining his streak of top-10 starts, while Sebastian Murray rebounded from an early setback with a career-best fifth-place finish in INDY NXT by Firestone, earning top honors for the Andretti fleet. SEGG Media Chairman and CEO Matthew McGahan said the exposure underscored the value promised…

TuesdayJul 29, 2025 9:00 am

QualityStocksNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Receives FDA Fast Track Designation for CLD-201 in Soft Tissue Sarcoma

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company developing targeted genetic medicine delivery therapies, announced that the U.S. Food and Drug Administration granted Fast Track designation to CLD-201 (SuperNova), its allogeneic adipose stem-cell loaded oncolytic virus for treating soft tissue sarcoma. The designation provides opportunities for expedited development, including priority review and accelerated approval. CLD-201, which received IND clearance in April, will enter a Phase 1 trial evaluating safety and efficacy in sarcoma, triple-negative breast cancer, and head and neck squamous cell carcinoma. Chief Medical Officer Guy Travis Clifton, M.D., said the milestone validates CLD-201’s potential to deliver durable,…

MondayJul 28, 2025 11:17 am

QualityStocksNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Showcases Drivers at Laguna Seca Java House Grand Prix of Monterey

SEGG Media (NASDAQ: SEGG, LTRYW), a technology company at the intersection of sports, entertainment and gaming, announced that Lottery.com and Sports.com-sponsored drivers Callum Ilott, Louis Foster and Sebastian Murray will compete at the Java House Grand Prix of Monterey at WeatherTech Raceway Laguna Seca. Foster, driving the #45 Droplight Honda for Rahal Letterman Lanigan Racing, enters the event with an average starting position of 8.4 over the last five races and aims to convert his strong qualifying pace into points. Ilott returns to the circuit where he secured his career-best IndyCar finish of P5 in 2023, while Murray makes his…

MondayJul 28, 2025 9:45 am

QualityStocksNewsBreaks – Bollinger Innovations, Inc. (NASDAQ: BINI) Completes Name and Ticker Change from Mullen Automotive

Bollinger Innovations (NASDAQ: BINI), an electric vehicle manufacturer, announced that its previously disclosed name change from Mullen Automotive Inc. to Bollinger Innovations, Inc. is effective as of July 28, 2025, along with its new Nasdaq stock symbol “BINI.” The company stated the transition unifies its commercial Class 1, 3 and 4 vehicles under a single brand identity. CEO and Chairman David Michery said the move marks the completion of the company’s brand evolution while having no impact on its legal structure or operations. No shareholder action is required as a result of the changes. To view the full press release,…

MondayJul 28, 2025 9:00 am

QualityStocksNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Appoints Dr. Lee T. Schalop to Board to Bolster AI-Driven Precision Oncology

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging artificial intelligence and genomic data to accelerate oncology drug discovery, announced the appointment of Lee T. Schalop, MD, to its Board of Directors. Dr. Schalop, co-founder and former CEO of Oncoceutics Inc., brings over 20 years of experience in biotechnology leadership and financial markets, with a track record in developing targeted therapies for solid tumors, including HK327M-mutant gliomas. Oncoceutics was acquired by Chimerix Inc. (NASDAQ: CMRX) for $450 million in 2021 and later by Jazz Pharmaceuticals for $935 million in April 2025. Lantern CEO Panna Sharma said Dr. Schalop’s expertise in…

FridayJul 25, 2025 3:29 pm

QualityStocksNewsBreaks – Ucore Rare Metals Inc.’s (TSX.V: UCU) (OTCQX: UURAF) RapidSX(TM) Core to Blueprint to Secure Rare Earth Independence

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is positioned as a key player in a strategy to build a secure, independent rare earth supply chain in North America. Triggered by China’s export restrictions on key elements, a potential blueprint includes diversifying rare earth sources, using modular refining with Ucore’s RapidSX(TM) technology, anchoring refining with magnet-making hubs, establishing stockpiles and off-take agreements, and proving the chain with traceability and ESG standards. Ucore’s RapidSX(TM) is central to reducing bottlenecks in chemical separation, helping to develop a resilient, transparent, and strategically independent supply chain. To view the full article, visit https://ibn.fm/TkGA1 About Ucore…

FridayJul 25, 2025 3:18 pm

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB): Innovation Meets Science Through Scalable Platform

Nutriband (NASDAQ: NTRB) is positioning at the forefront of abuse-deterrent drug delivery in advancing its flagship fentanyl patch and buprenorphine candidates. The company combines transdermal innovation with abuse-deterrent science to meet critical public health needs. According to Nurtiband, AVERSA Fentanyl, with the possibility to reach peak annual U.S. sales of $80 to $200 million, holds the potential to be the world’s first opioid patch designed to deter the abuse and misuse and reduce the risk of accidental exposure of transdermal fentanyl patches. In addition, Nutriband is advancing AVERSA Buprenorphine, which upon approval is projected to achieve peak U.S. sales between…

FridayJul 25, 2025 3:10 pm

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Builds Momentum to Bring New Hope to Neuro Patients

Clene (NASDAQ: CLNN), together with its subsidiary Clene Nanomedicine Inc., is preparing to initiate neurofilament biomarker analyses for its lead drug candidate CNM-Au8(R) in ALS, following feedback from the FDA during a recent Type C meeting. Slated for early Q4 2025, the analyses will assess changes in neurofilament light chain (“NfL”)—a recognized marker for neurodegeneration—among nearly 200 patients treated through the Expanded Access Program for CNM-Au8. “We are encouraged by the FDA’s collaborative approach and their constructive feedback on our NfL biomarker analysis plan from the ongoing NIH-sponsored EAP program,” said Benjamin Greenberg, MD, Head of Medical at Clene. “With…

FridayJul 25, 2025 9:00 am

QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Spotlights Gold Strategy and Mill Acquisition on MiningNewsWire Podcast

LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0), a Canadian gold exploration and development company, is featured on the latest episode of The MiningNewsWire Podcast hosted by IBN. Chairman Kal Malhi and CEO Paul Ténière detail the company’s positioning as a near-term producer in Québec’s Abitibi Gold Belt, emphasizing its advanced Swanson Gold Project and fully permitted Beacon Mill. Malhi discusses acquiring the mill through a strategic bankruptcy bid, while Ténière highlights the company’s fast-track production path amid rising gold prices and growing regional opportunity. To view the full press release, visit https://ibn.fm/gcy5N About LaFleur Minerals Inc. LaFleur Minerals Inc.…

Site Search

Company Search

Category: QualityStocksNewsBreaks